Sandford D. Smith serves as Executive at GENZYME CORP, where they oversee executive responsibilities. Since joining the company, Sandford D. Smith has executed 152 insider transactions totaling $17.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2006 involved exercising options for 12,500 shares valued at $548.8K.
Sandford D. Smith currently holds 18,801 shares of GENZYME CORP (GENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandford D. Smith has been a net seller of GENZ stock. They have purchased $41.6K and sold $17.9M worth of shares.
Sandford D. Smith's most recent insider trade was on Mar 1, 2006, when they sold 12,500 shares at $43.90 per share.
Get notified when new Form 4 filings are submitted
| $69.12 |
| Discretionary |